EYVUE

Serial Number 98391842
730

Registration Progress

Application Filed
Feb 5, 2024
Under Examination
Apr 1, 2025
Approved for Publication
Oct 15, 2024
Published for Opposition
Oct 15, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Apr 01, 2026 94 days

Trademark Image

EYVUE

Basic Information

Serial Number
98391842
Filing Date
February 5, 2024
Published for Opposition
October 15, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Aug 22, 2025
Application
Pending
Classes
005

Rights Holder

Allergan Sales, LLC

16
Address
1 N. Waukegan Road
North Chicago, IL 60064

Ownership History

Allergan Sales, LLC

Original Applicant
16
North Chicago, IL

Allergan Sales, LLC

Owner at Publication
16
North Chicago, IL

Legal Representation

Attorney
Cheryl A. Withycombe

USPTO Deadlines

Next Deadline
94 days remaining
NOA E-Mailed - SOU Required
Due Date
April 01, 2026
Extension Available
Until October 01, 2026

Application History

14 events
Date Code Type Description Documents
Aug 23, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 22, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 22, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 22, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 1, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 23, 2025 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Nov 13, 2024 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Oct 15, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 15, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 25, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 6, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 28, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 12, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 8, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Eye drops; Ophthalmic preparations; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of ophthalmic conditions; Pharmaceutical preparations for the treatment of presbyopia

Additional Information

Pseudo Mark
EYE VIEW
Pseudo Mark
I VIEW

Classification

International Classes
005